Wave Life Sciences Ltd (WVE)

Wave Life Sciences Ltd (WVE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $745M; returns 1 day -5.1%, 1 week +1.6%, 1 year -54.9%.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing RNA medicines to treat rare and prevalent diseases. The company's revenue is primarily generated through strategic collaboration and licensing agreements with large pharmaceutical partners like GlaxoSmithKline (GSK), relying on upfront payments, research funding, and milestone achievements.

Groups WVE belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Life Sciences
• Healthcare
• Rare Diseases
• Duchenne Muscular Dystrophy
• Weight Management
• Strategic Partnerships

WVE financial model: income statement, cash flow and balance sheet